Lucid Diagnostics Inc. SEC filings LUCD

Lucid Diagnostics Inc. has 281 filings in SEC EDGAR's recent list, going back to Jan 21, 2020. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (unregistered share sale, change to shareholder rights, bylaw or fiscal year change). The company's fiscal year ends on December 31.

Lucid Diagnostics Inc. SEC filings
Form Description Filed Period
8-K Current report
Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Oct 22, 2026 Oct 21, 2026
8-K Current report
Listing notice
Oct 16, 2026 Oct 12, 2026
8-K Current report
Regulation FD disclosure
Sep 22, 2026 Sep 22, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2026 Aug 13, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 24, 2026 Jun 24, 2026
4 Insider transaction May 21, 2026 May 20, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 14, 2026 May 14, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
DEFA14A Additional proxy material Apr 30, 2026 —
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 30, 2026 Apr 30, 2026
3/A Amended initial statement of beneficial ownership of securities Apr 24, 2026 Mar 23, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 24, 2026 Apr 24, 2026
424B5 Prospectus supplement Apr 23, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 23, 2026 Apr 23, 2026
PRE 14A Preliminary proxy statement Apr 20, 2026 Apr 20, 2026
3 Initial insider ownership Apr 13, 2026 Mar 23, 2026
S-8 Employee stock plan registration Apr 3, 2026 —
S-8 Employee stock plan registration Apr 3, 2026 —
EFFECT Filing Mar 26, 2026 —
424B5 Prospectus supplement Mar 26, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Mar 26, 2026 Mar 26, 2026
S-3/A Filing Mar 26, 2026 —
CORRESP Letter to the SEC Mar 25, 2026 —
10-K Annual report Mar 25, 2026 Dec 31, 2025
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 9, 2026 —
S-3 Shelf registration Dec 5, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Nov 12, 2025 Nov 12, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 10, 2025 —
4 Insider transaction Oct 7, 2025 Oct 6, 2025
3 Initial insider ownership Oct 7, 2025 Sep 22, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 25, 2025 Sep 22, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 11, 2025 Sep 11, 2025
424B5 Prospectus supplement Sep 10, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Sep 10, 2025 Sep 10, 2025
424B5 Prospectus supplement Sep 9, 2025 —
4 Insider transaction Aug 22, 2025 Aug 20, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2025 Aug 13, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Shareholder vote results
Jun 18, 2025 Jun 18, 2025
424B3 Prospectus Jun 3, 2025 —
EFFECT Filing May 30, 2025 —
8-K Current report
Material agreement
May 30, 2025 May 30, 2025
424B5 Prospectus supplement May 30, 2025 —
CORRESP Letter to the SEC May 27, 2025 —
UPLOAD Letter from the SEC May 27, 2025 —
4/A Amended statement of changes in beneficial ownership of securities May 23, 2025 May 20, 2025
4 Insider transaction May 22, 2025 May 20, 2025
S-3 Shelf registration May 22, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
May 14, 2025 May 14, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
DEFA14A Additional proxy material Apr 30, 2025 —
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 30, 2025 Apr 30, 2025
8-K Current report
Auditor change
Apr 25, 2025 Apr 23, 2025
PRE 14A Preliminary proxy statement Apr 18, 2025 Apr 18, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 11, 2025 Apr 11, 2025
424B5 Prospectus supplement Apr 10, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 10, 2025 Apr 9, 2025
424B5 Prospectus supplement Apr 9, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Mar 25, 2025 Mar 24, 2025
10-K Annual report Mar 24, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure, Other events
Mar 5, 2025 Mar 5, 2025
424B5 Prospectus supplement Mar 5, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Mar 4, 2025 Mar 4, 2025
8-K Current report
Other events
Mar 4, 2025 Mar 4, 2025
8-K Current report
Other events
Feb 25, 2025 Feb 24, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
S-8 Employee stock plan registration Jan 31, 2025 —
S-8 Employee stock plan registration Jan 31, 2025 —
8-K Current report
Other events
Dec 20, 2024 Dec 19, 2024
SC 13D/A Amended ownership over 5% (active) Dec 12, 2024 —
D Filing Dec 6, 2024 —
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Change to shareholder rights
Nov 29, 2024 Nov 22, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights
Nov 18, 2024 Nov 12, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2024 Nov 13, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Change to shareholder rights
Nov 12, 2024 Nov 8, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2024 Aug 12, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jul 24, 2024 Jul 23, 2024
424B3 Prospectus Jul 19, 2024 —
EFFECT Filing Jul 18, 2024 —
CORRESP Letter to the SEC Jul 15, 2024 —
S-3/A Filing Jul 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jul 8, 2024 —
UPLOAD Letter from the SEC Jul 8, 2024 —
S-3 Shelf registration Jul 1, 2024 —
8-K Current report
Listing notice
Jun 21, 2024 Jun 21, 2024
DEF 14A Proxy statement Jun 6, 2024 Jun 6, 2024
DEFA14A Additional proxy material Jun 6, 2024 —
PRE 14A Preliminary proxy statement May 24, 2024 May 24, 2024
DEFA14A Additional proxy material May 24, 2024 —
8-K Current report
Other events
May 24, 2024 May 24, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 14, 2024 May 13, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
4 Insider transaction May 9, 2024 May 8, 2024
3 Initial insider ownership May 9, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 7, 2024
4 Insider transaction May 8, 2024 May 7, 2024
4 Insider transaction May 8, 2024 May 7, 2024
4 Insider transaction May 8, 2024 May 7, 2024
8-K Current report
Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
May 7, 2024 May 1, 2024
8-K Current report
Regulation FD disclosure
May 2, 2024 May 2, 2024
DEFA14A Additional proxy material Apr 29, 2024 —
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 29, 2024 Apr 29, 2024
PRE 14A Preliminary proxy statement Apr 19, 2024 Apr 18, 2024
10-K Annual report Mar 25, 2024 Dec 31, 2023
8-K Current report
Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Mar 14, 2024 Mar 13, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
SC 13D/A Amended ownership over 5% (active) Feb 20, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
S-8 Employee stock plan registration Feb 6, 2024 —
S-8 Employee stock plan registration Feb 6, 2024 —
SC 13D/A Amended ownership over 5% (active) Feb 2, 2024 —
4 Insider transaction Jan 30, 2024 Jan 26, 2024
8-K Current report
Unregistered share sale
Jan 30, 2024 Jan 26, 2024
8-K Current report
Listing notice
Nov 28, 2023 Nov 27, 2023
8-K Current report
Listing notice
Nov 24, 2023 Nov 21, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2023 Nov 13, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Officer or director change
Nov 13, 2023 Nov 6, 2023
D Filing Nov 1, 2023 —
8-K Current report
Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Oct 18, 2023 Oct 17, 2023
4 Insider transaction Sep 27, 2023 Sep 25, 2023
4/A Amended statement of changes in beneficial ownership of securities Sep 27, 2023 Sep 20, 2023
144 Notice of proposed sale Sep 26, 2023 —
4 Insider transaction Sep 22, 2023 Sep 20, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 21, 2023 Jun 21, 2023
EFFECT Filing Jun 1, 2023 —
424B3 Prospectus Jun 1, 2023 —
CORRESP Letter to the SEC May 26, 2023 —
UPLOAD Letter from the SEC May 26, 2023 —
S-3 Shelf registration May 23, 2023 —
10-Q Quarterly report May 15, 2023 Mar 31, 2023
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement May 1, 2023 May 1, 2023
PRE 14A Preliminary proxy statement Apr 19, 2023 Apr 19, 2023
4/A Amended statement of changes in beneficial ownership of securities Apr 13, 2023 Nov 30, 2022
3 Initial insider ownership Apr 6, 2023 Mar 18, 2022
D Filing Apr 5, 2023 —
8-K Current report
Regulation FD disclosure
Apr 3, 2023 Mar 31, 2023
8-K Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights
Mar 24, 2023 Mar 21, 2023
SC 13G/A Amended ownership over 5% (passive) Mar 24, 2023 —
SC 13G Ownership over 5% (passive) Mar 23, 2023 —
D Filing Mar 22, 2023 —
8-K Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Change to shareholder rights, Regulation FD disclosure
Mar 14, 2023 Mar 13, 2023
10-K Annual report Mar 14, 2023 Dec 31, 2022
8-K Current report
Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Mar 13, 2023 Mar 7, 2023
8-K Current report
Agreement ended, Unregistered share sale
Feb 17, 2023 Feb 14, 2023
8-K Current report
Regulation FD disclosure
Feb 16, 2023 Feb 15, 2023
S-8 Employee stock plan registration Feb 10, 2023 —
S-8 Employee stock plan registration Feb 10, 2023 —
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Feb 2, 2023 Jan 31, 2023
8-K Current report
Regulation FD disclosure, Other events
Jan 18, 2023 Jan 17, 2023
424B5 Prospectus supplement Dec 7, 2022 —
EFFECT Filing Dec 6, 2022 —
4 Insider transaction Dec 2, 2022 Nov 30, 2022
SC 13D/A Amended ownership over 5% (active) Dec 2, 2022 —
8-K Current report
Unregistered share sale
Dec 2, 2022 Nov 30, 2022
CORRESP Letter to the SEC Dec 1, 2022 —
UPLOAD Letter from the SEC Dec 1, 2022 —
S-3 Shelf registration Nov 25, 2022 —
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2022 Nov 14, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
4 Insider transaction Sep 22, 2022 Sep 20, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
LUCD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
, Emerging growth company
SEC CIK
1799011

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.